Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Minoxidil effectively treats female pattern hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Genetic marker rs12558842 strongly linked to male hair loss.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.